Skip to content

This website is intended for UK healthcare professionals only

This is a promotional website developed by AstraZeneca

The prescribing information can be found at the bottom of the page


Tagrisso Case Study: Second line EGFRm+ NSCLC – 63F

Dr David Woolf, Consultant Clinical Oncologist, Christie NHS Foundation Trust